UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

UCLA Institute of Urologic Oncology


News & Highlights

Observing Men with Very Low- and Low-Risk Prostate Cancer Very Effective and Underused

Jul 06, 2015
Dr. Mark Litwin & Dr. Leonard S. Marks -- Observation not aggressive treatment appropriate for many prostate cancers. Monitoring men with very low- and low-risk prostate cancers using watchful waiting or active surveillance, called expectant management, is a useful approach for a large number of men with localized tumors and could spare them the debilitating side effects of aggressive treatments that are too often unnecessarily used in this patient population, a UCLA review of common practices in prostate cancer has found.
Story on medicalxpress.com » Additional Coverage: examiner.com | Watchful Waiting & Active Surveillance at UCLA

Age-Adjusted Comorbidity Score Can Stratify Mortality in Prostate Cancer

Jun 25, 2015
Dr. Timothy Daskivich -- (HealthDay) An age-adjusted prostate cancer-specific comorbidity index (PCCI) can stratify the risk of long-term nonprostate cancer-related mortality, according to a study published in the July issue of The Journal of Urology. Timothy J. Daskivich, M.D., from the David Geffen School of Medicine at the University of California-Los Angeles, and colleagues sampled 1,598 men diagnosed with prostate cancer between 1998 and 2004.
Story on medicalxpress.com » Additional Coverage: empr.com | doctorslounge.com

Fusion Biopsy Study Presentation Receives Coverage

Mar 17, 2015
Dr. Christopher Filson -- Uro Today on May 17, OncLive , News-Medical.net and PharmiWeb on May 18 and MedPage Today May 19 reported on a study by Dr. Christopher Filson that found biopsy guided by a fusion of magnetic resonance imaging and ultrasound improves detection of aggressive prostate cancer compared with mapping or targeting alone. Filson, a UCLA urologic oncology and health services research fellow, presented the findings at the American Urology Association meeting in New Orleans.

Researchers For The First Time Measure Cost of Care For a Common Prostate Condition

Mar 10, 2015
Dr. Alan Kaplan -- How much does health care really cost? UCLA researchers have for the first time described cost across an entire care process for a common condition called benign prostate hyperplasia (BPH) using time-driven activity-based costing. They found a 400 percent discrepancy between the least and most expensive ways to treat the condition.
Article on newswise.com » Additional Coverage: Medicalxpress.com

Are Too Many Prostate Cancer Patients Receiving Treatment?

Feb 19, 2015
Dr. Karim Chamie -- (HealthDay News) Study also raises concerns about possible overuse of radiation therapy. New research suggests that a wait-and-watch approach for prostate cancer isn't being used often enough, and that more men are being treated than may be necessary. Additionally, the researchers expressed concern about the numbers of men being treated with radiation therapy, regardless of their tumor specifics. "Too many men are being treated for prostate cancer, and too many are being treated with radiation therapy," said study lead author Dr. Karim Chamie, an assistant professor of urology at the University of California, Los Angeles.
Article on consumer.healthday.com »

Novel Imaging Technique Improves Prostate Cancer Detection

Jan 10, 2015
Dr. Leonard S. Marks -- In 2014, prostate cancer was the leading cause of newly diagnosed cancers in men and the second leading cause of cancer death in men. Writing in the 6 January 2015 issue of the journal Prostate Cancer and Prostatic Disease, a team of scientists and physicians from the University of California, San Diego School of Medicine, with counterparts at University of California, Los Angeles, describe a novel imaging technique that measurably improves upon current prostate imaging – and may have significant implications for how patients with prostate cancer are ultimately treated.
Story on domain-b.com »
| Targeted Prostate Biopsy »

UCLA and UC San Diego Scientists Report That New Imaging System Provides More Data on Prostate Cancer

Jan 06, 2015
Dr. Robert Reiter -- Scientists at UCLA and UC San Diego reported today that a new imaging system is providing more precise data on prostate cancer, the second leading cause of death in men. In today’s issue of the journal Prostate Cancer and Prostatic Disease, the researchers said current magnetic resonance imaging systems have flaws, but a restriction spectrum imaging MRI corrects them, allowing physicians to accurately plot a tumor’s location and extent. “If by imaging we could predict the tumor grade, we may be able to spare some patients from prostate resection and monitor their cancer with imaging,” said Dr. Robert Reiter, a professor of urology at UCLA.
Story on westsidetoday.com » Additional Coverage: health.ucsd.edu, mynewsla.com

George Christy Talks About “Movember”, UCLA Institute of Urologic Oncology and More!

Nov 26, 2014
Drs. Holden, Belldegrun & Litwin on bhcourier.com -- Movember! The month when men are encouraged, and justifiably with their wives’ support, to grow that “upper lip topiary.” So called by a smart ass UCLA professor as a synonym for the mustache to draw awareness to men’s health in the month of November. Lately established as a global Movember signature, the “topiary” is deemed to be fun, spark conversation with explanations that it’s high time for men’s health to be acknowledged with a symbol. Notably about the prostate, informs the renowned urologist/oncologist Dr. Stuart “Skip” Holden, whose patient is Michael Milken. One of the evening’s hosts, Dr. Holden is a restaurant devotee who hits the road in our town to check out any new eatery the minute the doors are unlocked (a Doctor Foodie, if you will). As the associate director during the formal opening of the UCLA Institute of Urologic Oncology, he welcomed guests along with Doctors Arie Belldegrun, the director, and Mark Litwin, the department chair. All sporting the “upper lip topiary.”
Story on Beverly Hills Courier »

Researcher Makes Case for MRI Use in Prostate Biopsies

Nov 03, 2014
Dr. Leonard S. Marks -- Leonard S. Marks, a professor of urology at UCLA School of Medicine, routinely uses MRI on prostate-cancer patients. Since 2009, he and colleagues have conducted about 1,400 MRI-fusion biopsies in 1,100 men. In a study published last year in the Journal of Urology, the researchers found that MRI-guided biopsies were three times as likely to identify cancer compared with a conventional biopsy. Another finding: 38% of the men with high-grade cancer had disease detected only when MRI was used. “Over and over again we see cancers that have been missed by conventional biopsy that are detected by targeted fusion biopsies,” said Dr. Marks.
Story on The Wall Street Journal »
| Targeted Prostate Biopsy »

Quality of Biopsy Directly Linked to Survival in Patients with Bladder Cancer

Oct 28, 2014
Dr. Karim Chamie -- For about half of those with the disease, doctors don’t get a sufficient sample to correctly stage the cancer. UCLA researchers have shown for the first time that the quality of diagnostic staging when performing biopsies on patients with bladder cancer is directly linked with survival, meaning those who don’t get optimal biopsies are more likely to die from their disease. The two-year study found that about half of bladder cancer patients who were biopsied had insufficient material — meaning that no bladder wall muscle was retrieved — to accurately stage the cancer.
Article on healthcanal.com » Additional Coverage: Oncology Update, Doctors Lounge, Monthly Prescribing Reference, PriMed, Urology Times, Medical Device Online, HCP Live, Oncologynurseadvisor.com, Healio.com, Brief Penn Live

KFI Radio - Prostate Cancer Awareness Month

Sep 24, 2014
Dr. Mark Litwin on KFI Radio -- KFI's Bill Carroll interviewed Dr. Litwin regarding Prostate Cancer Awareness Month. This interview focused on understanding prostate cancer and why screening is key for certain high risk groups.
On-Air Interview with Bill Carroll (MP3) »

UCLA Rated One of the Top Hospitals in the Nation